tiprankstipranks
Radnet Inc (CH:PQIA)
:PQIA

Radnet (PQIA) Price & Analysis

0 Followers

PQIA Stock Chart & Stats

Currently, no data available
Please return soon. This page is being updated.

Bulls Say, Bears Say

Bulls Say
AI Platform EfficiencyDeepHealth's digital platform supports AI models that can shorten MRI scan times and increase scans per machine, boosting facility capacity and improving operating margins.
Market PositioningShift of imaging from hospitals to lower-cost outpatient centers, combined with a large multi-state RadNet network, positions the company to capture increasing scan volume and offer faster, more cost-efficient services than hospital competitors.
New Revenue StreamAI-enabled mammography has led to detection of many breast cancers and is attracting out-of-pocket payments and some payor reimbursements, creating a growing revenue stream beyond traditional imaging fees.
Bears Say
Limited New InformationAnalyst notes the report largely reiterates already disclosed information, which may limit positive market reaction due to lack of fresh catalysts.
Stock-based CompensationElevated stock-based compensation tied to development of the DeepHealth business increases reported expenses and could pressure profitability and per-share metrics until compensation levels normalize.

Radnet News

PQIA FAQ

What was Radnet Inc’s price range in the past 12 months?
Currently, no data Available
What is Radnet Inc’s market cap?
Radnet Inc’s market cap is CHF4.85B.
    When is Radnet Inc’s upcoming earnings report date?
    Radnet Inc’s upcoming earnings report date is Mar 02, 2027 which is in 181 days.
      How were Radnet Inc’s earnings last quarter?
      Radnet Inc released its earnings results on Aug 09, 2026. The company reported CHF0.235 earnings per share for the quarter, beating the consensus estimate of CHF0.163 by CHF0.072.
        Is Radnet Inc overvalued?
        According to Wall Street analysts Radnet Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Radnet Inc pay dividends?
          Radnet Inc does not currently pay dividends.
          What is Radnet Inc’s EPS estimate?
          Radnet Inc’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Radnet Inc have?
          Radnet Inc has 78,697,754 shares outstanding.
            What happened to Radnet Inc’s price movement after its last earnings report?
            Radnet Inc reported an EPS of CHF0.235 in its last earnings report, beating expectations of CHF0.163. Following the earnings report the stock price went same N/A.
              Which hedge fund is a major shareholder of Radnet Inc?
              Currently, no hedge funds are holding shares in CH:PQIA
              What is the TipRanks Smart Score and how is it calculated?
              Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                Company Description

                Radnet Inc

                RadNet, Inc. operates as a prominent healthcare services company specializing in outpatient diagnostic imaging across the United States. Their comprehensive offerings span a broad spectrum of advanced imaging techniques, including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, and general diagnostic radiology, along with various specialized procedures. Beyond direct patient services, the company also plays a significant role in developing and marketing specialized computerized systems for the diagnostic imaging sector, such as picture archiving communication systems (PACS) and associated support. Furthermore, RadNet is at the forefront of integrating artificial intelligence (AI) solutions, designing and deploying AI suites to augment radiologist interpretation, particularly in mammography, and extending these AI capabilities to lung and prostate cancer diagnostics. As of December 31, 2021, its operational footprint included ownership and management of 347 centers situated across seven states: Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. Established in 1981, the company maintains its headquarters in Los Angeles, California.

                Radnet (PQIA) Earnings & Revenues

                PQIA Earnings Call

                Q2 2026
                0:00 / 0:00
                Earnings Call Sentiment|Positive
                The call presented strong operational and financial momentum: record company revenue and adjusted EBITDA, robust advanced imaging growth and mix improvement, meaningful Digital Health ARR acceleration and commercial funnel expansion, successful acquisitions/integrations, and a major FDA clearance for breast ultrasound AI. Near-term pressures include deliberate Digital Health investment-driven margin dilution, labor cost inflation, integration/implementation expenses, and reimbursement/regulatory uncertainty. Overall, the positive operational execution, liquidity position, guidance raises for the imaging segment, and clear path to scale Digital Health ARR and profitability outweigh the transitory challenges noted.View all CH:PQIA earnings summaries

                PQIA Stock 12 Month Forecast

                Average Price Target

                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
                Similar Stocks
                Company
                Price & Change
                Follow
                Neogen
                Revvity
                NeoGenomics
                Sotera Health
                Popular Stocks